Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1700570

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Neurodiversity: Women
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will commission research into the impact of (a) autism and (b) ADHD on women.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	21455
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is currently funding research to address measurement bias in the assessment of the presentation of autism in women, and to develop a new psychometric tool assessing the female-dominant phenotype of autism. The NIHR previously funded a study to improve the accuracy and efficiency of autism assessment for adults which, while not specific to women, will be relevant to their experiences of receiving a diagnosis. The NIHR has also funded research into topics that impact autistic individuals differently, for example how to adapt suicide safety plans to address self-harm, suicidal ideation, and suicide behaviours in autistic adults.</p><p>The NIHR welcomes funding applications for research into any aspect of human health, including the impact of autism and attention deficit hyperactivity disorder on women. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 11:36:36 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4620 label Biography information for Ellie Reeves

1700572

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Autism: Premenstrual Dysphoric Disorder
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will commission research into the reasons for which autistic women are more likely to suffer from premenstrual dysphoric disorder throughout their lives.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	21457
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is not currently funding any specific research to understand the reasons why autistic women are more likely to suffer from premenstrual dysphoric disorder, but welcomes funding applications for research into any aspect of human health. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money, and scientific quality.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 11:17:41 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4620 label Biography information for Ellie Reeves

1700571

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Neurodiversity: Women
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will commission research into the impact of hormonal changes on neurodiverse women throughout their lives.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	21456
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is not currently funding any specific research into the impact of hormonal changes on neurodiverse women, but welcomes funding applications for research into any aspect of human health. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money, and scientific quality.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 11:14:48 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4620 label Biography information for Ellie Reeves

1700510

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make it her policy to allow pharmacies to sell vitamin B12 injections.
	tabling member constituency	Loughborough
	tabling member printed	Jane Hunt
	uin	21397
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>To make a medicinal product available for sale in a pharmacy without a prescription, the product must be reclassified to pharmacy only status, also known as [P] medicines, by the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p>This process is triggered by an application submitted to the MHRA by a company which holds a licence for the particular product. The MHRA will consider all submitted applications, with a decision to reclassify a medicine reached following a robust evaluation of the relevant data, including evidence of the safe use and supply of the product without a prescription. The company must also demonstrate in their application that the criteria specified in relevant legislation, such as the Human Medicines Regulations 2012, have been met.</p><p>In accordance with the Human Medicines Regulations 2012, regulation 62(3), Prescription-Only Medicine status will apply where: a direct or indirect danger exists to human health, even when used correctly, if used without medical supervision; there is frequently incorrect use, which could lead to direct or indirect danger to human health; further investigation of the activity or side-effects is required; or the product is normally prescribed for parenteral administration, via injection.</p><p>Currently, United Kingdom law specifies that all products administered by injection must be subject to a prescription. The MHRA is therefore unable to reclassify the status of injections, including Vitamin B12, to [P] medicines, as this would not be consistent with the legislation.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 11:03:29 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4839 label Biography information for Jane Hunt

1700334

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether her Department has made a recent assessment of the potential merits of using breast density assessment software at women's first breast cancer screening appointments; and if she will make an assessment of the potential impact of that technology on women's awareness of their personal risk of developing breast cancer.
	tabling member constituency	North Warwickshire
	tabling member printed	Craig Tracey
	uin	21156
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The Breast Screening Risk Adaptive Imaging for Density trial is looking into the use of supplementary imaging techniques for women, within the standard breast screening programme, who are found to have radiographically dense breast tissue. The UK National Screening Committee, which advises ministers and the National Health Service in all four countries in the United Kingdom, will review this evidence when it becomes available.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 10:56:31 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4509 label Biography information for Craig Tracey

1700548

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Wellingborough
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support the recruitment and retention of mental health specialists in Wellingborough constituency.
	tabling member constituency	Wellingborough
	tabling member printed	Gen Kitchen
	uin	21433
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>To deliver the NHS Long Term Plan’s mental health commitments and help reduce waiting times in the Wellingborough constituency and nationwide, our aim has been to grow the mental health workforce nationally by an additional 27,000 professionals by March 2024.</p><p> </p><p>We are making positive progress, delivering three quarters of this, or approximately 20,800 new professionals, by December 2023, with further growth expected to have been achieved once the full year figures for 2023/24 are available. This growth is in addition to the commitment to grow the National Health Service’s mental health workforce by 19,000 between 2016/17 and 2020/21, as set out in Stepping Forward to 2020/21: the mental health workforce plan for England, which was achieved in September 2021.</p><p> </p><p>At a national level, we are committed to attracting, training, and recruiting the mental health workforce of the future, as well as retaining and developing our current workforce. The NHS Long Term Workforce Plan’s modelling projections set out a need to grow the overall mental health and learning disability workforce the fastest of all care settings, at 4.4% per year up to 2036/37, to help improve access to services and quality of care.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 16/04/2024 10:53:27 answering member 4492 label Biography information for Maria Caulfield
	tabling member	5011 label Biography information for Gen Kitchen

1699135

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services: Supported Housing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of variations in access to appropriate social care provision to enable independent living on the (a) availability and (b) capacity of supported accommodation.
	tabling member constituency	Nottingham East
	tabling member printed	Nadia Whittome
	uin	20822
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>Our white paper People at the Heart of Care sets out our ambition to ensure people have the choice and control to remain independent in the community. We recognise that supported housing can be the best model of care for some people, leading to better health, greater independence, and closer connection with the community.</p><p>The forthcoming provisions of the Supported Housing (Regulatory Oversight) Act 2023 will strengthen the data on the availability and capacity of supported accommodation. The act places a new duty on local housing authorities to review the supported housing in each district, and to forecast future need. The Government will consult on the implementation of the new duties and other supported housing reforms in due course.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 16/04/2024 10:51:14 answering member 4527 label Biography information for Helen Whately
	tabling member	4869 label Biography information for Nadia Whittome

1698563

	registered interest
	date	25/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding her Department plans to provide for research and development into HIV in the (a) 2024-25 and (b) 2025-26 financial year.
	tabling member constituency	Vauxhall
	tabling member printed	Florence Eshalomi
	uin	20481
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The Department supports research and development on the human immunodeficiency virus (HIV) through the National Institute for Health and Care Research (NIHR). For the financial years 2024/25 and 2025/26, the Government has committed to a new £20 million research project to evaluate an expansion of HIV opt-out testing, in 47 emergency departments in England where HIV prevalence is high.</p><p>However, NIHR funding awarded for HIV projects varies depending on the volume and quality of applications received and approved via open competition, which means overall NIHR funding for HIV research in the financial years 2024/25 and 2025/26 is not yet known. The NIHR welcomes funding applications for research into any aspect of human health, including HIV.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 10:44:38 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4870 label Biography information for Florence Eshalomi

1698562

	registered interest
	date	25/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding her Department has provided for research and development into a (a) cure and (b) vaccine for HIV in each year since 2019.
	tabling member constituency	Vauxhall
	tabling member printed	Florence Eshalomi
	uin	20480
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The Department supports research on the human immunodeficiency virus (HIV) through the National Institute for Health and Care Research (NIHR). The remit of the NIHR is translational, clinical, and applied healthcare research. Basic research towards the development of a novel cure or vaccine for HIV is supported by other research funders such as the Medical Research Council. The NIHR has awarded over £10 million of funding since 2019 for research to evaluate new HIV treatments. The below table shoes the specific NIHR spend on HIV treatments, for each financial year since 2019:</p><table><tbody><tr><td><p>Year</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td><td><p>2023/24</p></td><td><p>Total</p></td></tr><tr><td><p>NIHR spend</p></td><td><p>£3,260,413</p></td><td><p>£1,884,962</p></td><td><p>£1,299,676</p></td><td><p>£2,377,284</p></td><td><p>£1,209,822</p></td><td><p>£10,032,156</p></td></tr></tbody></table> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 10:41:29 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4870 label Biography information for Florence Eshalomi

1697850

	registered interest
	date	21/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genetics: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many patients in the South West have been eligible for pre-implantation genetic testing for monogenic disorders in each of the last five years.
	tabling member constituency	Bristol East
	tabling member printed	Kerry McCarthy
	uin	19828
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>Pre-implantation Genetic Testing (PGT) is used to identify genetic anomalies in embryos created through in-vitro fertilisation. Over 600 genetic conditions can currently be tested for using this technique, as licensed by the Human Fertilisation and Embryology Authority. NHS England has commissioned five centres to provide PGT to patients in England. The number of PGT cycles undertaken has increased from 223 patients in 2009 to 620 in 2019, but NHS England does not have access to data that describes the geographical profile of the people that have used the National Health Service or privately commissioned PGT services.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 10:39:37 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1491 label Biography information for Kerry McCarthy